Today, I want to walk you through one of the most effective, evidence-based strategies we have for combating menopause-related visceral fat: the combination of GLP-1 medications and hormone therapy
Karagiannis T, Avgerinos I, Liakos A et al (2022) Management of type 2 diabetes with the dual GIP/GLP-1 receptor agonist tirzepatide: a systematic review and meta-analysis
This study was performed by using a controlled transection of the motor branch of the femoral peripheral nerve in an experimental model
As noted by Mahiques-Santos, the higher incidence of side effects associated with MT-II is due to its being less receptor-specific than MT-I [1]
If you or a family member has experienced serious complications after taking a GLP-1 drug such as Ozempic, Wegovy, Mounjaro, or Zepbound, our Chicago product liability lawyers are here to help
Because the goal isnt just weight lossits a life that finally feels like your own